y 27632 has been researched along with pyrimidine in 1 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (pyrimidine) | Trials (pyrimidine) | Recent Studies (post-2010) (pyrimidine) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 2,159 | 6 | 950 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brett, SE; Luykenaar, KD; Welsh, DG; Wiehler, WB; Wu, BN | 1 |
1 other study(ies) available for y 27632 and pyrimidine
| Article | Year |
|---|---|
Pyrimidine nucleotides suppress KDR currents and depolarize rat cerebral arteries by activating Rho kinase.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Animals; Cerebral Arteries; Enzyme Inhibitors; Female; Intracellular Signaling Peptides and Proteins; Membrane Potentials; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Potassium Channels; Protein Kinase C; Protein Serine-Threonine Kinases; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; rho-Associated Kinases; Uridine Triphosphate; Vasoconstrictor Agents | 2004 |